CWM
AGN.PRA

Calamos Wealth Management’s Allergan plc AGN.PRA Stock Holding History

Calamos Wealth Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,306
Closed -$766K – 236
2017
Q4 		$766K Sell
1,306
-420
-24% -$271K 0.1% 136
2017
Q3 		$1.27M Buy
1,726
+650
+60% +$540K 0.18% 121
2017
Q2 		$934K Sell
1,076
-35
-3% -$29.3K 0.13% 144
2017
Q1 		$944K Sell
1,111
-155
-12% -$128K 0.14% 149
2016
Q4 		$965K Sell
1,266
-2,959
-70% -$2.24M 0.16% 159
2016
Q3 		$3.47M Sell
4,225
-341
-7% -$295K 0.59% 54
2016
Q2 		$3.81M Buy
4,566
+1,044
+30% +$872K 0.67% 43
2016
Q1 		$3.24M Sell
3,522
-15
-0.4% -$14.3K 0.62% 44
2015
Q4 		$3.64M Sell
3,537
-10
-0.3% -$10K 0.73% 38
2015
Q3 		$3.35M Buy
3,547
+117
+3% +$122K 0.8% 36
2015
Q2 		$3.58M Buy
+3,430
New +$3.59M 0.84% 30

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Calamos Wealth Management's AGN.PRA Position: Q1 2018 in Review

Calamos Wealth Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 1,306 shares — an estimated $766K sold.

Calamos Wealth Management first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $3.81M in Q2 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Calamos Wealth Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Calamos Wealth Management sold 1,306 Allergan plc shares in Q1 2018, an estimated $766K.
  • Calamos Wealth Management first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Calamos Wealth Management's Allergan plc position peaked at $3.81M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Calamos Wealth Management's 13F filing for Q1 2018, filed 13 Apr 2018.